Clinical Trial Update: Study of Oral MD-0727 Administered to Patients With Primary Hypercholesterolemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating oral MD-0727 in patients with primary hypercholesterolemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• MD-0727

Snippet

Sponsor: Ironwood Pharmaceuticals, Inc. | Conditions: Hypercholesterolemia | Phase 2 | Status: COMPLETED